Christopher W. Slavinsky - Net Worth and Insider Trading

Christopher W. Slavinsky Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher W. Slavinsky owns 1 companies in total, including Phathom Pharmaceuticals Inc (PHAT) .

Click here to see the complete history of Christopher W. Slavinsky’s form 4 insider trades.

Insider Ownership Summary of Christopher W. Slavinsky

Ticker	Comapny	Transaction Date	Type of Owner
PHAT	Phathom Pharmaceuticals Inc	2019-10-24	director

Christopher W. Slavinsky Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher W. Slavinsky Ownership Network

Ownership Network List of Christopher W. Slavinsky

No Data

Ownership Network Relation of Christopher W. Slavinsky

Christopher W. Slavinsky Owned Company Details

What does Phathom Pharmaceuticals Inc do?

Who are the key executives at Phathom Pharmaceuticals Inc?

Christopher W. Slavinsky is the director of Phathom Pharmaceuticals Inc. Other key executives at Phathom Pharmaceuticals Inc include Chief Operating Officer Azmi Nabulsi , CFO and CBO Molly Henderson , and 10 percent owner Takeda Pharmaceutical Co Ltd .

Phathom Pharmaceuticals Inc (PHAT) Insider Trades Summary

Over the past 18 months, Christopher W. Slavinsky made no insider transaction in Phathom Pharmaceuticals Inc (PHAT). Other recent insider transactions involving Phathom Pharmaceuticals Inc (PHAT) include a net sale of 32,756 shares made by Molly Henderson , a net sale of 50,699 shares made by Terrie Curran , and a net sale of 3,703,703 shares made by Takeda Pharmaceutical Co Ltd .

In summary, during the past 3 months, insiders sold 0 shares of Phathom Pharmaceuticals Inc (PHAT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,798,059 shares of Phathom Pharmaceuticals Inc (PHAT) were sold and 7,500 shares were bought by its insiders, resulting in a net sale of 3,790,559 shares.

Phathom Pharmaceuticals Inc (PHAT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Phathom Pharmaceuticals Inc Insider Transactions

No Available Data

Christopher W. Slavinsky Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher W. Slavinsky. You might contact Christopher W. Slavinsky via mailing address: C/o Phathom Pharmaceuticals, Inc., 2150 E. Lake Cook Road, Suite 800, Buffalo Grove Il 60089.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.